ROPIVACAINE ALTAN 2 mg/ml, solution for infusion 5 bags of 200 ml
Active ingredients: Ropivacaine hydrochloride, (S)-N-(2,6-dimethylphenyl)-1-ethylpiperidine-2-carboxamide
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusion5 bags of 200 mlpéridurale;périneurale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROPIVACAINE ALTAN 2 mg/mL, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- péridurale;périneurale
- Presentation description
- 5 poches non-PVC (Polyoléfine) de 200 mL avec une surface non stérile avec un suremballage amovible.
- Marketing authorisation holder
- ALTAN PHARMACEUTICALS (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Mar 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List II: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64576012CIP75506222CIP133400955062226Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE ROPIVACAÏNE MONOHYDRATÉsolution | — | SA |
| CHLORHYDRATE DE ROPIVACAÏNEsolution | 2 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.